729 filings
Page 6 of 37
8-K
byhn8n
11 Apr 22
Aptose Announces Executive Management Changes
5:04pm
S-8 POS
m50fdxsz8banbxj 5a7
1 Apr 22
Registration of securities for employees (post-effective amendment)
4:52pm
8-K
8so6x27
22 Mar 22
Aptose Reports Results for the Fourth Quarter and Full Year 2021
4:05pm
8-K
ayy6wswbz1amisv9qk3
20 Dec 21
Aptose Provides Update on APTO-253 Program
7:30am
8-K
o387bk9t7t0 a9zj
13 Dec 21
HM43239 Data Featured in Oral Presentation at theĀ American Society of Hematology Annual Meeting
4:35pm
8-K
v1j9co39h17
12 Nov 21
Aptose Reports Results for the Third Quarter 2021
6:40am
8-K
eh0 zf14xx
4 Nov 21
Aptose Enters into Exclusive Worldwide License Agreement with Hanmi
5:17pm
8-K
ceodmet25bxigs07
4 Nov 21
Aptose Clinical Data to be Presented at the 2021 ASH Annual Meeting
9:00am
8-K
2o00hyjx4oxvvnbi rh
25 Oct 21
Other Events
8:05am
8-K
ze4qql3
3 Aug 21
Aptose Reports Results for the Second Quarter 2021
4:05pm
S-8
42r62 qmr
28 Jun 21
Registration of securities for employees
12:00am
8-K
z2kp4u8
11 Jun 21
Aptose Presents Highlights from EHA During Corporate Update Event
8:00am
8-K
xxsix15
1 Jun 21
Aptose Biosciences Announces Results of Annual Meeting of Shareholders
4:30pm
8-K
o8617 prc
4 May 21
Aptose Reports Results for the First Quarter 2021
4:01pm